Long-term, double-blind, randomized parallel group studies comparing fenbufen with indometacin in patients with osteoarthritis.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D010654:Phenylbutyrates; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D011897:Random Allocation
D000893:Anti-Inflammatory Agents; D010654:Phenylbutyrates; D011422:Propionates; C010725:fenbufen; D007213:Indomethacin